Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
September 28, 2026 · 6:45 AM · NEW YORK
Pfizer Inc. (NYSE: PFE) will present data from 45 company-sponsored, investigator-sponsored, and collaborative research abstracts at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026 in Madrid, Spain. The presentations include 11 oral presentations spanning Pfizer’s established medicines and late-stage pipeline across its disease areas of focus, including breast cancer, genitourinary cancers, and lung cancer.
- PublishedSeptember 28, 2026 · 6:45 AM
- LocationNEW YORK
- IndustryHealth
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →